-
Something wrong with this record ?
Multi-pathogen infections and Alzheimer's disease
D. Vigasova, M. Nemergut, B. Liskova, J. Damborsky
Language English Country Great Britain
Document type Journal Article, Review
Grant support
CZ.02.1.01/0.0/0.0/16_026/0008451
Czech Ministry of Education
TN01000013
Technologická Agentura České Republiky
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-04-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Alzheimer Disease drug therapy microbiology MeSH
- Anti-Infective Agents therapeutic use MeSH
- Antiviral Agents pharmacology therapeutic use MeSH
- Biofilms drug effects MeSH
- Humans MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with the overproduction and accumulation of amyloid-β peptide and hyperphosphorylation of tau proteins in the brain. Despite extensive research on the amyloid-based mechanism of AD pathogenesis, the underlying cause of AD is not fully understood. No disease-modifying therapies currently exist, and numerous clinical trials have failed to demonstrate any benefits. The recent discovery that the amyloid-β peptide has antimicrobial activities supports the possibility of an infectious aetiology of AD and suggests that amyloid-β plaque formation might be induced by infection. AD patients have a weakened blood-brain barrier and immune system and are thus at elevated risk of microbial infections. Such infections can cause chronic neuroinflammation, production of the antimicrobial amyloid-β peptide, and neurodegeneration. Various pathogens, including viruses, bacteria, fungi, and parasites have been associated with AD. Most research in this area has focused on individual pathogens, with herpesviruses and periodontal bacteria being most frequently implicated. The purpose of this review is to highlight the potential role of multi-pathogen infections in AD. Recognition of the potential coexistence of multiple pathogens and biofilms in AD's aetiology may stimulate the development of novel approaches to its diagnosis and treatment. Multiple diagnostic tests could be applied simultaneously to detect major pathogens, followed by anti-microbial treatment using antiviral, antibacterial, antifungal, and anti-biofilm agents.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026169
- 003
- CZ-PrNML
- 005
- 20211026133142.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12934-021-01520-7 $2 doi
- 035 __
- $a (PubMed)33509204
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Vigasova, Dana $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
- 245 10
- $a Multi-pathogen infections and Alzheimer's disease / $c D. Vigasova, M. Nemergut, B. Liskova, J. Damborsky
- 520 9_
- $a Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with the overproduction and accumulation of amyloid-β peptide and hyperphosphorylation of tau proteins in the brain. Despite extensive research on the amyloid-based mechanism of AD pathogenesis, the underlying cause of AD is not fully understood. No disease-modifying therapies currently exist, and numerous clinical trials have failed to demonstrate any benefits. The recent discovery that the amyloid-β peptide has antimicrobial activities supports the possibility of an infectious aetiology of AD and suggests that amyloid-β plaque formation might be induced by infection. AD patients have a weakened blood-brain barrier and immune system and are thus at elevated risk of microbial infections. Such infections can cause chronic neuroinflammation, production of the antimicrobial amyloid-β peptide, and neurodegeneration. Various pathogens, including viruses, bacteria, fungi, and parasites have been associated with AD. Most research in this area has focused on individual pathogens, with herpesviruses and periodontal bacteria being most frequently implicated. The purpose of this review is to highlight the potential role of multi-pathogen infections in AD. Recognition of the potential coexistence of multiple pathogens and biofilms in AD's aetiology may stimulate the development of novel approaches to its diagnosis and treatment. Multiple diagnostic tests could be applied simultaneously to detect major pathogens, followed by anti-microbial treatment using antiviral, antibacterial, antifungal, and anti-biofilm agents.
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $x mikrobiologie $7 D000544
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiinfekční látky $x terapeutické užití $7 D000890
- 650 _2
- $a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Nemergut, Michal $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
- 700 1_
- $a Liskova, Barbora $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
- 700 1_
- $a Damborsky, Jiri $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. jiri@chemi.muni.cz $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. jiri@chemi.muni.cz
- 773 0_
- $w MED00008244 $t Microbial cell factories $x 1475-2859 $g Roč. 20, č. 1 (2021), s. 25
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33509204 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133148 $b ABA008
- 999 __
- $a ok $b bmc $g 1715010 $s 1146676
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 20 $c 1 $d 25 $e 20210128 $i 1475-2859 $m Microbial cell factories $n Microb Cell Fact $x MED00008244
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_026/0008451 $p Czech Ministry of Education
- GRA __
- $a TN01000013 $p Technologická Agentura České Republiky
- LZP __
- $a Pubmed-20211013